Polar Asset Management Partners Inc. bought a new position in shares of CME Group Inc. (NASDAQ:CME – Free Report) during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 78,317 shares of the financial services provider’s stock, valued at approximately $17,295,000.
Other hedge funds have also added to or reduced their stakes in the company. Jupiter Topco LLC acquired a new position in CME Group in the 2nd quarter valued at $395,519,000. EFG International AG bought a new position in CME Group during the 2nd quarter worth $33,768,000. Ancora Advisors LLC acquired a new stake in shares of CME Group during the second quarter worth $53,000. Primecap Management Co. CA acquired a new stake in shares of CME Group during the second quarter worth $420,602,000. Finally, PDT Partners LLC bought a new stake in shares of CME Group in the second quarter valued at about $13,250,000. 87.75% of the stock is owned by institutional investors and hedge funds.
CME Group Trading Down 0.7%
Shares of CME Group stock opened at $277.32 on Wednesday. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. CME Group Inc. has a 12-month low of $218.31 and a 12-month high of $329.16. The company has a market capitalization of $99.72 billion, a price-to-earnings ratio of 23.52, a PEG ratio of 3.32 and a beta of 0.23. The firm’s 50-day moving average price is $251.75 and its two-hundred day moving average price is $279.35.
CME Group Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Friday, September 25th. Shareholders of record on Wednesday, September 9th will be paid a dividend of $1.30 per share. The ex-dividend date is Wednesday, September 9th. This represents a $5.20 annualized dividend and a yield of 1.9%. CME Group’s dividend payout ratio is presently 44.11%.
Insiders Place Their Bets
In other CME Group news, Director William R. Shepard bought 325 shares of the business’s stock in a transaction on Thursday, June 25th. The stock was purchased at an average cost of $230.57 per share, for a total transaction of $74,935.25. Following the completion of the purchase, the director directly owned 260,442 shares of the company’s stock, valued at approximately $60,050,111.94. This trade represents a 0.12% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website. 0.30% of the stock is owned by insiders.
Analyst Ratings Changes
CME has been the topic of several research reports. UBS Group decreased their price target on shares of CME Group from $310.00 to $260.00 and set a “buy” rating on the stock in a research note on Monday, July 6th. Keefe, Bruyette & Woods upgraded shares of CME Group from a “market perform” rating to an “outperform” rating and set a $305.00 price objective for the company in a research note on Thursday, June 18th. Barclays dropped their price objective on shares of CME Group from $316.00 to $270.00 and set an “equal weight” rating for the company in a research note on Thursday, July 9th. Erste Group Bank downgraded shares of CME Group from a “buy” rating to a “hold” rating in a report on Friday, June 5th. Finally, Morgan Stanley increased their target price on shares of CME Group from $324.00 to $330.00 and gave the stock an “overweight” rating in a research report on Thursday, July 23rd. Nine analysts have rated the stock with a Buy rating, six have given a Hold rating and three have issued a Sell rating to the stock. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $288.56.
View Our Latest Analysis on CME Group
CME Group Company Profile
CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.
The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.
Read More
- Five stocks we like better than CME Group
- Pathward’s Credit Scare Tests Its Comeback Story
- Wiring the AI Boom: Rumble’s $13.7B Pivot
- StoneX: Too Far Too Fast?
- DICK’s Sporting Goods Faces Pain Now for a Bigger Prize
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.
